Computation screening and molecular docking of FDA approved viral protease inhibitors as a potential drug against COVID-19

AIM: This study demonstrated potent inhibitors against COVID-19 using the molecular docking approach of FDA approved viral antiprotease drugs. BACKGROUND: COVID-19 has now spread throughout world. There is a serious need to find potential therapeutic agents. The 3C-like protease (Mpro/6LU7) is an at...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Gastroenterol Hepatol Bed Bench
Autores principales: Absalan, Abdorrahim, Doroud, Delaram, Salehi-Vaziri, Mostafa, Kaghazian, Hooman, Ahmadi, Nayebali, Zali, Fatemeh, Pouriavali's, Mohamamd Hassan, Mousavi-Nasab, Seyed Dawood
Formato: Artigo
Lenguaje:Inglês
Publicado: Shaheed Beheshti University of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7682959/
https://ncbi.nlm.nih.gov/pubmed/33244378
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares